[1]
“Rational Design and In-Silico Evaluation of a Multi-Epitope Vaccine Targeting Human Glypican-3 (GPC3) for Hepatocellular Carcinoma Immunotherapy”, VER, vol. 8, no. 10s, pp. 203–216, Nov. 2025, Accessed: Apr. 08, 2026. [Online]. Available: https://verjournal.com/index.php/ver/article/view/812